CRINESSITY Trademark

Trademark Overview


On Friday, September 3, 2021, a trademark application was filed for CRINESSITY with the United States Patent and Trademark Office. The USPTO has given the CRINESSITY trademark a serial number of 97010788. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, July 24, 2024. This trademark is owned by Neurocrine Biosciences, Inc.. The CRINESSITY trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia
crinessity

General Information


Serial Number97010788
Word MarkCRINESSITY
Filing DateFriday, September 3, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, July 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2022

Trademark Statements


Goods and Servicespharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Monday, May 9, 2022PRIORITY ACTION WRITTEN
Tuesday, September 7, 2021NEW APPLICATION ENTERED
Friday, October 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 3, 2022ASSIGNED TO EXAMINER
Monday, May 9, 2022PRIORITY ACTION E-MAILED
Monday, May 9, 2022NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, November 2, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 6, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 26, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, July 26, 2023SOU EXTENSION 1 FILED
Wednesday, July 26, 2023SOU EXTENSION 1 GRANTED
Tuesday, January 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 23, 2024SOU EXTENSION 2 FILED
Tuesday, January 23, 2024SOU EXTENSION 2 GRANTED
Wednesday, July 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 24, 2024SOU EXTENSION 3 FILED
Wednesday, July 24, 2024SOU EXTENSION 3 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED